Results: Of the total 305 students sampled, 153 (50.2%) fit the category of depression. Concerning burnout, only 5.6% of the total population met the Maslach Burnout Inventory diagnostic criteria for burnout, with those determined to have burnout having ranked high on the emotional exhaustion and cynicism subscales, and low on the academic efficacy subscale. Male was strongly associated with burnout, while female gender and raising children were strongly associated with the presence of depression. Emotional exhaustion and high cynicism as determinants of burnout elevate the risk of depression. Conclusion: Our results highlight the high rate of depression and burnout, as well as the need for psychological intervention programs at medical schools to prevent the deterioration of student's mental health that has been associated with advancement in medical school.

One of the rare dermatological illnesses that might cause a medical emergency is SJS/TEN. SJS/TEN trigger an aggressive immune reaction to destroy the epithelium of the skin and mucous membranes. They are lifethreatening mucocutaneous responses with death rates as high as 30% and a wide range of acute and chronic morbidities. Therefore, early detection and adequate and early treatment can save the patient's life. To review the evaluation of SJS/TEN clinical manifestations and the different aspects of the management. PubMed database search engine was the preferred method for data selection, and the following keys were used in the mesh (("Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis"[Mesh] ) AND ("evaluation"[Mesh]) OR ("management"[Mesh])). While there is no test or set of criteria that can determine whether or not an individual has Steven-Johnson syndrome or Toxic epidermal Necrolysis, a skin biopsy can assist in determining other illnesses that have clinical manifestations.Provided there is no effective approach to treat SJS/TEN, presently the best approach is to have a great doubt for the syndrome, early clinical diagnosis, immediate discontinuation of suspected causing substance, supportive therapy, and close monitoring for and treatment of high morbidity complications like infection and ophthalmologic sequelae. Moreover, pain control is crucial to retain a sense of the mental and physical wellbeing of the patients.

Introduction In obese patients, hiatal hernia (HH) can be asymptomatic or may present with one or few symptoms, such as heartburn, nausea, or vomiting. Routine upper gastrointestinal (GI) endoscopy is the most frequent method used to determine the presence of any abnormalities, including HH. This study aimed to assess the prevalence of asymptomatic HH in obese patients during routine upper GI endoscopy assessments and to examine the correlation with body mass index (BMI). Materials and methods This was an observational, retrospective cohort study conducted at King Fahad Specialist Hospital, Buraydah, Qassim, Saudi Arabia. The data were extracted from the medical records and electronic charts of all obese patients who underwent preoperative upper GI endoscopy assessment between January 2017 and December 2019. Data were tabulated in Microsoft Excel and analyzed using the Statistical Package for the Social Sciences (SPSS) Version 21 (IBM Corp., Armonk, NY, USA). Results Among the 690 obese patients, HH was found in 103 (14.9%) patients. The chi-square test revealed that abdominal pain (X 2 =3.885; p=0.049), shortness of breath (X 2 =8.057; p=0.005), vomiting (X 2 =4.302; p=0.038), nausea (X 2 =4.090; p=0.043), and other HH symptoms (X 2 =3.897, p=0.048) were the most frequently reported HH related symptoms, but BMI was not (X 2 =2.126; p=0.345). In the multivariate regression model, the use of PPI (proton-pump inhibitor) medication (adjusted OR [AOR]=0.237; 95% CI=0.074-0.760; p=0.023) was found to be higher in those with HH. Vomiting (AOR=1.722; 95% CI=1.025-2.890; p=0.040) and nausea (AOR=1.698; 95% CI=1.012-2.849; p=0.045) were the most frequently reported symptoms related to HH. Conclusion Asymptomatic HH among obese patients is not widely prevalent in our region. The use of PPI medications was found to decrease the symptoms associated with HH, such as vomiting and nausea. However, there was no evidence linking BMI to the development of HH.

Background In obese patients, hiatus hernia (HH) can be asymptomatic or it may present with one or few symptoms such as heartburn, nausea, or vomiting. Routine upper gastrointestinal endoscopy is the most frequent method to determine the presence of any abnormalities including hiatus hernia. The aim of this study is to assess the prevalence of asymptomatic hiatal hernia in obese patients in routine upper GI endoscopy assessment and correlation with BMI. Methods This was an observational retrospective cohort study conducted at King Fahad Specialist hospital - Buraydah, Qassim, Saudi Arabia. The data were extracted from the medical records and electronic charts of all obese patients who had preoperative upper gastrointestinal endoscopy assessment between January 2017 – December 2019. Data were tabulated in Microsoft Excel and were analyzed using SPSS version 21. Results Among the 690 obese patients, the prevalence of HH was 103 yielding an overall percentage of 14.9%. Chi-square test revealed that the abdominal pain (X2=3.885; p=0.049), shortness of breath (X2=8.057; p=0.005), vomiting (X2=4.302; p=0.038), nausea (X2=4.090; p=0.043) and other HH symptoms (X2=3.897; p=0.048) significantly influenced HH but the BMI level did not (X2=2.126; p=0.345). In multivariate regression model, the use of PPI medication (AOR=0.237; CI=0.074 – 0.760; p=0.023), while vomiting (AOR=1.722; CI=1.025 – 2.890; p=0.040) and nausea (AOR=1.698; CI=1.012 – 2.849; p=0.045) significantly increased the risk of HH. Conclusion Asymptomatic HH among obese patients is not widely prevalent in our region. The use of PPI medications was found to decrease the symptoms associated with HH while symptoms such as vomiting and nausea increased the risk of HH. However, there was no evidence found linking BMI to HH as shown in this study.

Background: The neurological involvement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported in studies and its effect on the respiratory system. This study intended to assess the knowledge of neurological symptoms of COVID-19 among the Al'Qassim population, Saudi Arabia. Methods: This cross-sectional study was conducted on 529 Al'Qassim residents through an online survey. A COVID -19 online questionnaires was distributed via various messenger groups and social media. The questionnaire comprised of three sections to collect data regarding demographics, self-reported knowledge of neurologic symptoms, and neurological symptoms of COVID-19 for those who contracted COVID-19. For quantitative variables, mean and standard deviation were used, whereas for categorical variables, frequency and proportion were used. Results: Among the study population, the majority (35.34%) were aged between 18 to 24 years, and females (70.32%) outnumbered males (29.68%). The majority of the participants had acceptable (41.78%) knowledge of neurologic symptoms. The self-reported prevalence of COVID-19 among the respondents was 19.66%. Conclusion:Most respondents showed an acceptable to excellent knowledge of neurologic symptoms of COVID-19. However, this study found that females and younger age groups had better knowledge even though there was no statistical significance. Hence, health education intervention must be conducted targeting the vulnerable population to raise awareness of the disease's neurologic symptoms for early identification and prompt treatment.